Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Depression News

Women With Perinatal Depression May Have a Higher Mortality Risk, Study Finds
News
Women With Perinatal Depression May Have a Higher Mortality Risk, Study Finds
02/05/2024
Women with perinatal depression could have an increased mortality risk, particularly due to suicide, regardless of pre-existing psychiatric disorders or familial factors, according to recent results from a matched cohort study published in...
Women with perinatal depression could have an increased mortality risk, particularly due to suicide, regardless of pre-existing psychiatric disorders or familial factors, according to recent results from a matched cohort study published in...
Women with perinatal depression...
02/05/2024
Psych Congress Network
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
News
Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms
12/28/2023
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.
Patients who received deep...
12/28/2023
Psych Congress Network

Advertisement

News
For Treatment-Resistant Depression, Ketamine and ECT Offer Similar Effectiveness
12/24/2023
Seemingly contradictory findings from recent studies comparing intravenous (IV) ketamine with electroconvulsive therapy (ECT) in outpatients with treatment-resistant depression may have practicing clinicians feeling unsure about which...
Seemingly contradictory findings from recent studies comparing intravenous (IV) ketamine with electroconvulsive therapy (ECT) in outpatients with treatment-resistant depression may have practicing clinicians feeling unsure about which...
Seemingly contradictory findings...
12/24/2023
Psych Congress Network
News
Compass Pathways Initiates Phase 3 Study of Psilocybin for Treatment-Resistant Depression
11/27/2023
Compass Pathways, which recently opened a new research center in London, has begun a multi-site study of investigational psilocybin treatment of treatment-resistant depression.
Compass Pathways, which recently opened a new research center in London, has begun a multi-site study of investigational psilocybin treatment of treatment-resistant depression.
Compass Pathways, which recently...
11/27/2023
Psych Congress Network
A woman sits on the floor with her head in her hands looking depressed.
News
Long-Term Exposure to Air Pollution May Raise Risk for Postpartum Depression
11/15/2023
Long-term antepartum and postpartum exposure to ozone and particulate matter have been found to increase the risk for postpartum depression (PPD) among pregnant women living in Southern California.
Long-term antepartum and postpartum exposure to ozone and particulate matter have been found to increase the risk for postpartum depression (PPD) among pregnant women living in Southern California.
Long-term antepartum and...
11/15/2023
Psych Congress Network

Advertisement

Andrew Penn, RN, PMHNP, and Charles Raison, MD
News
Studies Illustrate Potential of MDMA-, Psilocybin-Assisted Therapies
10/30/2023
Andrew Penn, RN, PMHNP, and Charles Raison, MD, shared findings from late-stage trials for MDMA-assisted therapy to treat post-traumatic stress disorder and the use of psilocybin for treatment-resistant depression and major depressive...
Andrew Penn, RN, PMHNP, and Charles Raison, MD, shared findings from late-stage trials for MDMA-assisted therapy to treat post-traumatic stress disorder and the use of psilocybin for treatment-resistant depression and major depressive...
Andrew Penn, RN, PMHNP, and...
10/30/2023
Psych Congress Network
Sad neutral happy faces
News
Newly Approved MDD Drug Does Not Appear to Increase Risk of Sexual Dysfunction
10/18/2023
The US Food and Drug Administration (FDA) recently approved Exxua (gepirone hydrochloride extended-release [ER] tablets) for the treatment of major depressive disorder (MDD) in adults.
The US Food and Drug Administration (FDA) recently approved Exxua (gepirone hydrochloride extended-release [ER] tablets) for the treatment of major depressive disorder (MDD) in adults.
The US Food and Drug...
10/18/2023
Psych Congress Network
Single-Dose Psilocybin Linked With Rapid, Sustained Gains in Patients With MDD
News
Single-Dose Psilocybin Linked With Rapid, Sustained Gains in Patients With MDD
09/18/2023
A single 25-mg dose of psilocybin plus psychological support was associated with an improvement in depressive symptoms compared with active placebo in adults with MDD, according to a study published in JAMA.
A single 25-mg dose of psilocybin plus psychological support was associated with an improvement in depressive symptoms compared with active placebo in adults with MDD, according to a study published in JAMA.
A single 25-mg dose of...
09/18/2023
Psych Congress Network

Advertisement

A depressed man turns his head towards someone placing a comforting hand on his shoulder
News
Dementia Linked to Depression Diagnosis at Any Life Stage
08/15/2023
While depression has long been considered one of the first signs of dementia, a recent Danish population cohort study has shown that serious depression diagnosed at any life stage, even in early or mid-life, is associated with an increased...
While depression has long been considered one of the first signs of dementia, a recent Danish population cohort study has shown that serious depression diagnosed at any life stage, even in early or mid-life, is associated with an increased...
While depression has long been...
08/15/2023
Psych Congress Network
depression
News
TBI Affective Disorder May Be Distinct From Traditional Depression, MDD
07/13/2023
A new study has found physiological evidence that depression following traumatic brain injury (TBI) may be clinically distinct from traditional major depressive disorder (MDD).
A new study has found physiological evidence that depression following traumatic brain injury (TBI) may be clinically distinct from traditional major depressive disorder (MDD).
A new study has found...
07/13/2023
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use